Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Glutathione and Health With Post-Polio Syndrome

This study has been completed.
Penn State University
Information provided by (Responsible Party):
Claire Z. Kalpakjian, University of Michigan Identifier:
First received: July 25, 2011
Last updated: August 20, 2013
Last verified: August 2013
In this study, people who have symptoms of post polio will take oral glutathione supplements for three months. Their levels of fatigue, physical function, sleep disturbance, impairment and emotional distress will be measured with both subjective and objective measures.

Condition Intervention
Post-polio Syndrome
Physical Activity
Sleep Disorders
Dietary Supplement: Glutathione

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome

Resource links provided by NLM:

Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • Examine the effect of oral glutathione supplementation on people with late effects of poliomyelitis on measures of fatigue, physical functioning, sleep disturbance and emotional distress. [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    In this study, the subject's function, sleep patterns and emotional distress before and after taking a glutathione supplement.

Enrollment: 19
Study Start Date: August 2011
Study Completion Date: July 2013
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Glutathione supplement
All subjects will be taking a glutathione supplement.Glutathione is a naturally occuring antioxidant and a nonessential amino acid.
Dietary Supplement: Glutathione
glutathione is a dietary supplement and an antioxidant. Subjects will take 1000 mg per day for three month. Each capsule contains 500 mg glutathione.
Other Name: 500 Ultrathoine, GSH and l-glutathione.

Detailed Description:

Subjects will take a glutathione supplement by mouth for three months after an initial medical visit, blood draw and physical exam. There are four timepoints during the three months when subjects will fill out surveys and record food intake and sleep times in diaries for seven days. They will also wear a small device for seven days, a Sensewear monitor that records physical activity, body temperature and other measures.

After the fourth timepoint they will return to the medical center for another physical exam and blood draw. Physicians trained in physical medicine and rehabilitation will be monitoring the study.


Ages Eligible for Study:   50 Years to 65 Years   (Adult)
Genders Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Ability to walk 100 feet with usual assistive devices (ex. cane or walker)
  • Having a function score of 18-32 when tested with the IPPS (Index of Post- Polio Sequelae). This will include people with post-polio symptoms in a very specific range of severity.

Exclusion Criteria:

  • Having another serious medical condition (cancer, multiple sclerosis, etc.)or inflammatory disease (ie., lupus)
  • Currently taking glutathione or other antioxidants
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01402570

United States, Michigan
University of Michigan
Ann Arbor, Michigan, United States, 48108
Sponsors and Collaborators
University of Michigan
Penn State University
  More Information

Responsible Party: Claire Z. Kalpakjian, Assistant Professor, University of Michigan Identifier: NCT01402570     History of Changes
Other Study ID Numbers: PPH-1051 
Study First Received: July 25, 2011
Last Updated: August 20, 2013
Health Authority: United States: Federal Government

Keywords provided by University of Michigan:

Additional relevant MeSH terms:
Sleep Wake Disorders
Postpoliomyelitis Syndrome
Pathologic Processes
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Mental Disorders
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Central Nervous System Infections
Central Nervous System Diseases
Spinal Cord Diseases
Neuromuscular Diseases
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neurodegenerative Diseases processed this record on January 18, 2017